
Poulikos Poulikakos
@poulikos
Researcher focused on cancer and immune signaling and targeted therapies. Professor with tenure @TischCancer @SinaiImmunol
ID: 17519876
https://labs.icahn.mssm.edu/poulikakoslab/ 20-11-2008 19:48:52
203 Tweet
504 Followers
623 Following




Κυρία Niki Kerameus , εάν αποδειχτεί (που προσωπικά είμαι βέβαιος ότι αυτό συνέβη), ότι τα μέιλ διέρρευσαν από το Υπουργείο σας, δεν υπάρχει αυτονόητα θέμα για τον αν το ΥΠΕΣ μπορεί να διασφαλίσει τη διαδικασία της επιστολικής ψήφου;


Thank you for the warm hospitality and the stimulating discussions Inna Smalley 🇺🇦 and Keiran Smalley !


Much appreciation to a rising star Bhattacharyya Lab, visiting us today from Yale School of Medicine, for delivering an outstanding The Tisch Cancer Institute seminar. Amazing new technologies to visualize protein complexes in native membranes, with numerous applications





Looking forward to co-hosting this one day symposium Icahn School of Medicine at Mount Sinai in NYC with Eric Vivier & Innate Pharma and discussing the future of immunotherapy with all the fantastic immunologists from all career stages that can JOIN US Oct 3. FREE TO REGISTER: innate-symposium.com


🎉Congratulations🥳 Bhardwaj Lab Dr. Nina Bhardwaj, elected to National Academy of Medicine for advancing our understanding of human dendritic cell cross-presentation pathways and adjuvanticity, ‘pivotal discoveries which underlie the first approval of a cell-based vaccine in cancer.’

Cell Discovering IL-4's role in ovarian cancer was made possible with Perturb-map spatial functional genomics and great collaborations between Brown Lab Baccarini lab Miriam Merad, MD, PhD Peter Sorger and @SantagataLab Dmitriy Zamarin MD PhD and Chiara Falcomatà Jia-Ren Lin Nelson LaMarche.


Check out our new story! Mechanisms of innate and adaptive immune activation in cancer cells deficient in SMARCA4. Thank you to the multiple collaborators that made it possible. Nicolas Vabret Benjamin D. Greenbaum Mithat Gönen Kate Chiappinelli @chiappinellilab.bsky.social science.org/doi/full/10.11…



Our review article, "Resistance Mechanisms and Therapeutic Strategies for CDK4/6 Kinase Targeting in Cancer," is out today in Nature Cancer ! Check it out. rdcu.be/d75mG Evris Gavathiotis Christos Adamopoulos #PROTACs #CDK46 #CDK2 #Oncology #CancerImmunotherapy